Lv6
2290 积分 2023-03-12 加入
Hijacking ERAD for targeted degradation of transmembrane proteins
6天前
已完结
The story of amylin: from physiology to therapy
12天前
已完结
Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies
21天前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
21天前
已完结
Chemotherapeutic Drug—Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions
21天前
已完结
HRA00129-C004, a Novel c-Met Antibody–Drug Conjugate, Exerts Encouraging Antitumor Activities and Favorable Safety Profiles
22天前
已完结
SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
22天前
已完结
Journey of Methionine Adenosyltransferase 2A Inhibitors: From Bench to Advanced Clinical Trials
26天前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
1个月前
已完结
Antibody Drug Conjugates
1个月前
已完结
皖公网安备34019202002308
